Carmignac Gestion Baxter International Inc Transaction History

Carmignac Gestion

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $24 Million - $27.7 Million	-632,407 Reduced 11.91%	4,678,605 $200 Million
Q4 2023 Feb 13, 2024	BUY	$31.71 - $38.95 $14.7 Million - $18 Million	462,239 Added 9.53%	5,311,012 $205 Million
Q3 2023 Nov 13, 2023	BUY	$37.32 - $49.29 $149 Million - $197 Million	3,993,537 Added 466.95%	4,848,773 $183 Million
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $34.2 Million - $40.8 Million	855,236 New	855,236 $39 Million
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $124 Million - $136 Million	-1,649,620 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $10.3 Million - $11.9 Million	131,293 Added 8.65%	1,649,620 $133 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $119 Million - $143 Million	1,518,327 New	1,518,327 $131 Million
Q4 2019 Feb 13, 2020	SELL	$76.7 - $88.45 $52.6 Million - $60.7 Million	-685,950 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$81.4 - $89.78 $59.8 Million - $66 Million	-734,817 Reduced 51.72%	685,950 $60 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $34.4 Million - $38.6 Million	-468,120 Reduced 24.78%	1,420,767 $116 Million
Q1 2019 May 14, 2019	BUY	$64.48 - $81.31 $122 Million - $154 Million	1,888,887 New	1,888,887 $154 Million

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.